Invention Grant
- Patent Title: 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
-
Application No.: US16446253Application Date: 2019-06-19
-
Publication No.: US10653677B2Publication Date: 2020-05-19
- Inventor: Andrew P. Combs , Eddy W. Yue , Richard B. Sparks , Wenyu Zhu
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/08 ; A61K39/395 ; C07D413/12 ; C07D413/04 ; A61K39/00
Abstract:
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
Public/Granted literature
- US20190298700A1 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase Public/Granted day:2019-10-03
Information query
